Cognyte Software Ltd. (CGNT)
NASDAQ: CGNT
· Real-Time Price · USD
8.44
0.19 (2.30%)
At close: Oct 03, 2025, 3:59 PM
8.44
0.00%
After-hours: Oct 03, 2025, 04:10 PM EDT
Cognyte Software Revenue Breakdown
Period Ending | Jun 30, 2013 | Mar 31, 2013 | Sep 30, 2012 | Jun 30, 2012 |
---|---|---|---|---|
Industrial Revenue | 623K | 760K | 1.01M | 900K |
Industrial Revenue Growth | -18.03% | -25.12% | +12.78% | n/a |
Medical Revenue | 3.03M | 3.44M | 2.72M | 2.5M |
Medical Revenue Growth | -11.95% | +26.28% | +9.13% | n/a |
Revenue by Geography
Period Ending | Mar 31, 2015 |
---|---|
All Other Foreign Countries Revenue | 4.05M |
All Other Foreign Countries Revenue Growth | n/a |
United States Revenue | 19.97M |
United States Revenue Growth | n/a |
Operating Expense Breakdown
Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 36.9M | 38.23M | 36.76M | 34.76M | 33.77M | 33.3M | 32.62M | 31.31M | 28.8M | 35.07M | 36.83M | 39.04M | 43.4M | 46.85M | 43.06M | 45.14M | 50.82M | 49.36M | 40.21M | 32.73M | 40.29M | 42.75M | 42.75M | 36.75M | 36.75M | 31.2B | 7.75M | 7.41M | 2.14M | 346.52K |
Selling, General, and Administrative Revenue Growth | -3.48% | +3.98% | +5.76% | +2.95% | +1.38% | +2.09% | +4.19% | +8.72% | -17.89% | -4.76% | -5.67% | -10.04% | -7.36% | +8.80% | -4.61% | -11.17% | +2.95% | +22.76% | +22.84% | -18.75% | -5.76% | 0.00% | +16.34% | 0.00% | -99.88% | +402260.79% | +4.70% | +246.68% | +516.41% | n/a |
Research and Development Revenue | 29.1M | 28.08M | 27.19M | 26.18M | 26.78M | 27.04M | 25.4M | 27.1M | 27.75M | 30.67M | 33.13M | 38.55M | 37.98M | 38.29M | 35.53M | 36.13M | 33.41M | 36.53M | 31.92M | 29.07M | 31.19M | 31.23M | 31.23M | 27.34M | 27.34M | 4.74B | 1.23M | 1.03M | 1.29M | 1.39M |
Research and Development Revenue Growth | +3.64% | +3.25% | +3.87% | -2.24% | -0.94% | +6.45% | -6.29% | -2.32% | -9.53% | -7.43% | -14.06% | +1.50% | -0.81% | +7.78% | -1.67% | +8.13% | -8.53% | +14.43% | +9.81% | -6.80% | -0.12% | 0.00% | +14.23% | 0.00% | -99.42% | +383915.48% | +19.57% | -20.06% | -6.85% | n/a |